Claypond Capital, the family investment office of Ranjan Pai, announced that Shravan Subramanyam, the former Managing Director of Wipro-GE Healthcare, will head & lead the strategy and execution of their medical technology platform. The platform will focus on medical equipment and digital solutions for the domestic and export markets with an emphasis on localization and innovation.
Subramanyam is a physician from Madras Medical College with an MHA from Cornell University, with 20 years of experience in life sciences & medical devices companies including Roche and Novartis, across geographies. He was previously the president of NATHEALTH (Healthcare Federation of India) and co-chair of Medical Technology for FICCI & CII.
“The next decade holds a lot of promise for medical innovation and integration of various technologies, particularly digital solutions. I look forward to working closely with med-tech companies on behalf of Claypond, to scale up their presence in South Asia and overseas,” said Subramanyam.
Ranjan Pai said, “Healthcare delivery is changing profoundly in the post-Covid world, and medical technology has a big role to play in making healthcare accessible and affordable. Innovation will require long-term capital and collaboration between industry and academia. We believe the platform approach will address the opportunity for India to participate in the growth of the med-tech sector across regions.”
